Interleukin-13 upregulates vasodilatory 15-lipoxygenase eicosanoids in rabbit aorta

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 10, 2003, Pages 1768-1774

  Tang, Xin ^a   Spitzbarth, Nancy ^a   Kuhn, Hartmut ^b   Chaitidis, Pavlos ^b   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Arachidonic acid; Endothelium; Endothelium derived hyperpolarizing factor; Hydroxyeicosatetraenoic acid; Trihydroxyeicosatrienoic acid

Indexed keywords

11,12,15 TRIHYDROXYEICOSATRIENOIC ACID; 15 HYDROXY 11,12 EPOXYEICOSATRIENOIC ACID; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; ICOSANOID; ICOSATRIENOIC ACID; INDOMETACIN; INTERLEUKIN 13; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; CELL CULTURE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; METABOLISM; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA; ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONIC ACID; CARBON RADIOISOTOPES; EICOSANOIDS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-13; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; VASODILATION;

EID: 0141954212     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000092915.03128.73     Document Type: Article

References (38)

1. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007-2018.
2. Singer HA, Peach MJ. Endothelium-dependent relaxation of rabbit aorta, I: relaxation stimulated by arachidonic acid. J Pharmacol Exp Ther. 1983;226:790-795.
3. 2 and EETs in the relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 1993;264: H327-H335.
4. Campbell WB, Grebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
5. Pfister SL, Spitzbarth N, Nithipatikom K, Edgemond WS, Falck JR, Campbell WB. Identification of 11,14,15- and 11,12,15-trihydroxy-eicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J Biol Chem. 1998;273:30879-30887.
6. Ivanov I, Schwarz K, Holzhutter HG, Myagkova G, Kuhn H. ω-Oxidation impairs oxidizability of polyenoic fatty acids by 15-lipoxygenases: consequences for substrate orientation at the active site. Biochem J. 1998; 336:345-352.
7. Thiele BJ, Fleming J, Kasturi K, O'Prey J, Black E, Chester J, Rapoport SM, Harrison PR. Cloning of a rabbit erythroid-cell-specific lipoxygenase mRNA. Gene. 1987;57:111-119.
8. Kuhn H, Borngraber S. Mammalian 15-lipoxygenases: enzymatic properties and biological implications. In: Nigam S, Pace-Asciak C, eds. Lipoxygenases and Their Metabolites. Dordrecht, Netherlands: Kluwer Academic Publishers; 1999:5-28.
9. Kuhn H, Thiele BJ. Arachidonate 15-lipoxygenase. J Lipid Mediat Cell Signal. 1995;12:157-170.
10. Weaver JA, Maddox JF, Cao YZ, Mullarky IK, Sordillo LM. Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells. Free Radic Biol Med. 2001;30: 299-308.
11. Levy I, Wu Y-Q, Roeckel N, Bulle F, Pawkak A, Siegrist S, Mattei MG, Guellaen G. Human testis specifically expresses a homologue of the rodent T lymphocytes RT6 mRNA. FEBS Lett. 1996;382:276-280.
12. Cathcart MK, Folcik VA. Lipoxygenases and atherosclerosis: protection versus pathogenesis. Free Radic Biol Med. 2000;28:1726-1734.
13. Kuhn H, Heydeck D, Brinckman R, Trebus F. Regulation of cellular 15-lipoxygenase activity on pretranslational, translational, and posttranslational levels. Lipids. 1999;34(suppl):s273-279.
14. Conrad DJ, Kuhn H, Mulkins M, Highland E, Sigal E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci U S A. 1992;89:217-221.
15. Nassar GM, Morrow JD, Roberts LJ 2nd, Lakkis FG, Badr KF. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem. 1994;269:27631-27634.
16. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biological functions. Annu Rev Immunol. 1999;17:701-738.
17. Brombacher F. The role of interleukin-13 in infectious diseases and allergy. BioEssays. 2000;22:646-656.
18. Profita M, Vigonola AM, Sala A, Mirabella A, Siena L, Pace E, Folco G, Bonsignore G. Interleukin-4 enhances 15-lipoxygenase activity and incorporation of 15(S)-HETE into cellular phospholipids in cultured pulmonary epithelial cells. Am J Respir Cell Mol Biol. 1999;20:61-68.
19. Schnurr K, Borchert A, Kuhn H. Inverse regulation of lipid-peroxidizing and hydroperoxyl lipid-reducing enzymes by interleukins 4 and 13. FASEB J. 1999;13:143-154.
20. Lee YW, Kuhn H, Kaiser S, Kennig G, Daugherty A, Toborek M. Interleukin 4 induces transcription of the 15-lipoxygenase I gene in human endothelial cells. J Lipid Res. 2001;42:783-791.
21. Pfister SL, Spitzbarth N, Edgemond W, Campbell WB. Vasorelaxation by an endothelium-derived metabolite of arachidonic acid. Am J Physiol. 1996;270:H1021-H1030.
22. Song M, Zhu N, Olcese R, Barila B, Toro L, Stefani E. Hormonal control of protein expression and mRNA levels of the MaxiK channel α-subunit in myometrium. FEBS Lett. 1999;460:427-432.
23. Gauthier KM, Liu C, Popovic A, Albarwani S, Rusch NJ. Freshly isolated bovine coronary endothelial cells do not express the BK(Ca) channel gene. J Physiol. 2002;545:829-836.
24. Powell W. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylisilyl silica. Prostaglandins. 1980;20:947-957.
25. Brinckmann R, Schnurr K, Heydeck D, Rosenbach T, Kolde G, Kuhn H. Membrane translocation of 15-lipoxygenase in hematopoietic cells is calcium-dependent and activates the oxygenase activity of the enzyme. Blood. 1998;91:64-74.
26. Huang JT, Welsh JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK. Interleukin-4 dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature. 1999;400:378-382.
27. Jayawickreme SP, Gray T, Nettesheim P, Eling T. Regulation of 15-lipoxygenase expression and mucus secretion by IL-4 in human bronchial epithelial cells. Am J Physiol. 1999;276:L596-L603.
28. Brinckmann R, Topp MS, Zalan I, Heydeck D, Ludwig P, Kuhn H, Berdel WE, Habenicht JR. Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4. Biochem J. 1996;318:305-312.
29. Conrad DJ, Lu M. Regulation of human 12/15-lipoxygenase by Stat-6 dependent transcription. Am J Respir Cell Mol Biol. 2000;22: 226-234.
30. Heydeck D, Thomas L, Schnurr K, Trebus F, Ehierfelder WE, Ihle JN, Kuhn H. Interleukin-4 and -13 induce upregulation of the murine macrophage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6. Blood. 1998;92:2503-2510.
31. Roy B, Cathcart MK. Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes. J Biol Chem. 1998;273:32023-32029.
32. Xu B, Bahattacharjee A, Roy B, Xu H, Anthony D, Frank DA, Feldman GM, Cathcart MK. Interleukin-13 induction of 15-lipoxygenase gene expression requires p38 mitogen-activated protein kinase-mediated serine 727 phosphorylation of Stat1 and Stat3. Mol Cell Biol. 2003;23:3918-3928.
33. Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M, Hentze MW. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell. 1997;89: 597-606.
34. Ostareck-Lederer A, Ostareck DH, Standart N, Thiele BJ. Translation of 15-lipoxygenase mRNA is inhibited by a protein that binds to a repeated sequence in the 3′ untranslated region. EMBO J. 1994;13:1476-1481.
35. Harats D, Kurihara H, Levkovitz H, Shaish AS, Sigal E. 15-Lipoxygenase overexpression induces atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2000;20:2100-2105.
36. Cyrus T, Pratico D, Zhao L, Witztum JL, Rader DJ, Rokach J, FitzGerald GA, Funk CD. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice. Circulation. 2001;103:2277-2282.
37. George J, Afek A, Shaish AS, Levkovitz H, Bloom N, Cyrus T, Zhao L, Funk CD, Sigal E, Harats D. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation. 2001;104:1646-1650.
38. Shen J, Herderick E, Cornhill F, Zsigmond E, Kim HS, Kuhn H, Guevara NV, Chan L. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest. 1996;98:2201-2208.